{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:06:06Z","timestamp":1793563566780,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.pharmthera.2009.07.003","type":"journal-article","created":{"date-parts":[[2009,7,26]],"date-time":"2009-07-26T06:10:21Z","timestamp":1248588621000},"page":"259-268","source":"Crossref","is-referenced-by-count":172,"title":["Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome"],"prefix":"10.1016","volume":"124","author":[{"given":"Adarsh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harharpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.pharmthera.2009.07.003_bib1","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1016\/0098-2997(94)90040-X","article-title":"Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure","volume":"15","author":"Baggio","year":"1994","journal-title":"Mol Aspects Med"},{"issue":"22","key":"10.1016\/j.pharmthera.2009.07.003_bib2","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/eurheartj\/ehl158","article-title":"Coenzyme Q10 and exercise training in chronic heart failure","volume":"27","author":"Belardinelli","year":"2006","journal-title":"Eur Heart J"},{"issue":"1\u20134","key":"10.1016\/j.pharmthera.2009.07.003_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/biof.5520320115","article-title":"Oxidative stress, endothelial function and coenzyme Q10","volume":"32","author":"Belardinelli","year":"2008","journal-title":"BioFactors"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.07.003_bib4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/00007611-200111000-00015","article-title":"Randomized, double-blind, placebo-controlled trial of coenzyme q10 in isolated systolic hypertension","volume":"94","author":"Burke","year":"2001","journal-title":"South Med J"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0003-4975(94)91928-3","article-title":"Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting","volume":"58","author":"Chello","year":"1994","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.07.003_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","article-title":"Biochemical functions of coenzyme Q10","volume":"20","author":"Crane","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0006-3002(57)90457-2","article-title":"Isolation of a quinone from beef heart mitochondria","volume":"25","author":"Crane","year":"1957","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.07.003_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-5223(96)70455-5","article-title":"Elucidation of a tripartite mechanism underlying the improvement in cardiac tolerance to ischemia by coenzyme Q10 pretreatment","volume":"111","author":"Crestanello","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0098-2997(94)90036-1","article-title":"Coenzyme Q10 in essential hypertension","volume":"15","author":"Digiesi","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib10","series-title":"Coenzyme Q10. Pharmacist's letter\/prescriber's letter: Natural medicines comprehensive database","first-page":"172","author":"Ellin","year":"1999"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib11","first-page":"380","article-title":"Evidence for a deficiency of coenzyme Q10 in human heart disease","volume":"40","author":"Folkers","year":"1970","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1073\/pnas.82.3.901","article-title":"Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10","volume":"82","author":"Folkers","year":"1985","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib13","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1073\/pnas.87.22.8931","article-title":"Lovastatin decreases coenzyme Q levels in humans","volume":"87","author":"Folkers","year":"1990","journal-title":"Proc Natl Acad Sci"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2009.07.003_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1620\/tjem.141.Suppl_453","article-title":"Clinical study of cardiac arrhythmias using a 24-hour continuous electrocardiographic recorder (5th report) \u2014 antiarrhythmic action of coenzyme Q10 in diabetics","volume":"141","author":"Fujioka","year":"1983","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.07.003_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/j.1552-4604.1993.tb03948.x","article-title":"Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double blind, placebo-controlled study","volume":"33","author":"Ghirlanda","year":"1993","journal-title":"Clin Pharmocol J"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib16","first-page":"596","article-title":"Co-enzyme Ql0: a new drug for cardiovascular disease","volume":"30","author":"Greenberg","year":"1990","journal-title":"J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/00002018-200528080-00002","article-title":"The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical\/clinical implications","volume":"28","author":"Hargreaves","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yrtph.2006.05.006","article-title":"Risk assessment for coenzyme Q10 (ubiquinone)","volume":"45","author":"Hathcock","year":"2006","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib19","series-title":"Effects of coenzyme Q10 in patients with stable angina pectoris","first-page":"291","volume":"Vol. 4","author":"Hiasa","year":"1984"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.07.003_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.ejcn.1601464","article-title":"Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes","volume":"56","author":"Hodgson","year":"2002","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.07.003_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yrtph.2006.07.001","article-title":"Study on safety and bioavailability of ubiquinol after single and 4-week multiple oral administration to healthy volunteers","volume":"7","author":"Hosoe","year":"2007","journal-title":"Regul Toxicol Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.07.003_bib22","first-page":"546","article-title":"Comparison of coenzyme Q10 versus placebo in chronic heart failure","volume":"3","author":"Hosseini","year":"2008","journal-title":"Res J Biol Sci"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.65.1.1","article-title":"Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein","volume":"65","author":"Ignarro","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0006-291X(74)80480-8","article-title":"Deficiency of coenzyme Q10 in hypertensive rats and reduction of deficiency by treatment with coenzyme Q10","volume":"58","author":"Iwamoto","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib25","unstructured":"Judy, W.V., Hall, J.H., Dugan, W. (1984). Coenzyme Q10 reduction of adriamycin cardiotoxicity. In Biomedical and Clinical Aspects of Coenzyme Q, Vol. 4, ed. K Folkers, Y Yamamura. Amsterdam: Elsevier\/North Holland Biomedical Press, 231\u2013241."},{"key":"10.1016\/j.pharmthera.2009.07.003_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9149(85)90843-4","article-title":"Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris","volume":"56","author":"Kamikawa","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0885-4505(91)90024-F","article-title":"Effect of coenzyme Q10 on structural alterations in the renal membrane of stroke-prone spontaneously hypertensive rats","volume":"45","author":"Kamoto","year":"1991","journal-title":"Biochem Med Metab Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.07.003_bib28","first-page":"123","article-title":"Reduction in blood viscosity by treatment with coenzyme Q10 in patients with ischemic heart disease","volume":"28","author":"Kato","year":"1990","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib29","series-title":"Cellular Aspects of Smooth Muscle Function","author":"Kayo","year":"2005"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.07.003_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1443-9506.2003.00189.x","article-title":"Randomised double-blind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure","volume":"12","author":"Keogh","year":"2003","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.otohns.2006.07.010","article-title":"A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium","volume":"136","author":"Khan","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.7326\/0003-4819-132-8-200004180-00006","article-title":"The effect of coenzyme Q10 in patients with congestive heart failure","volume":"132","author":"Khatta","year":"2000","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.07.003_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1248\/jhs.54.571","article-title":"Can coenzyme Q10 lead to improvement of essential hypertension? A long-term case study","volume":"54","author":"Kimura","year":"2008","journal-title":"J Health Sci"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2009.07.003_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0098-2997(94)90023-X","article-title":"Coenzyme Q10 and antioxidants in acute myocardial infarction","volume":"15","author":"Kuklinski","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib35","series-title":"Third Conference of the International Coenzyme Q10 Association, London, UK","article-title":"Effect of Q gel (coenzyme Q10) in patients with end stage heart failure targetted for heart transplantation","author":"Kumar","year":"2002"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib36","series-title":"Adjunctive Coenzyme Q10 Therapy in 106 Cases of Acute Coronary Syndrome (ACS) Fourth Conference of the International Coenzyme Q10 Association, LA, USA","author":"Kumar","year":"2005"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib37","series-title":"Fourth Conference of the International Coenzyme Q10 Association, LA, USA","article-title":"Atorvastatin alone\/in combination with co-enzyme Q10 in 103 cases of ischemic dilated cardiomyopathy","author":"Kumar","year":"2005"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib38","series-title":"The 5th Conference of the International Coenzyme Q10 Association, Kobe Japan","article-title":"Coenzyme Q10 in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM)","author":"Kumar","year":"2007"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.07.003_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2143\/AC.62.4.2022278","article-title":"Effect of CarniQgel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study","volume":"62","author":"Kumar","year":"2007","journal-title":"Acta Cardiol"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.07.003_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00226853","article-title":"Italian multicenter study on the efficacy and safety of coenzyme Q10 as adjuvant therapy in heart failure","volume":"71","author":"Lampertico","year":"1993","journal-title":"Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.07.003_bib41","first-page":"169","article-title":"A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10","volume":"12","author":"Langsjoen","year":"1990","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib42","series-title":"5th Annual International CoQ10 Symposium. Kobe, Japan","author":"Langsjoen","year":"2007"},{"issue":"8 Suppl","key":"10.1016\/j.pharmthera.2009.07.003_bib43","first-page":"S140","article-title":"Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment","volume":"71","author":"Langsjoen","year":"1993","journal-title":"Clin Investig"},{"issue":"2\u20134","key":"10.1016\/j.pharmthera.2009.07.003_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/biof.5520090224","article-title":"Overview of the use of CoQ10 in cardiovascular disease","volume":"9","author":"Langsjoen","year":"1999","journal-title":"Biofactors"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib45","doi-asserted-by":"crossref","first-page":"s165","DOI":"10.1016\/0098-2997(94)90026-4","article-title":"Usefulness of coenzyme Q10 in clinical cardiology: a long-term study","volume":"15","author":"Langsjoen","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0098-2997(94)90037-X","article-title":"Treatment of essential hypertension with coenzyme Q10","volume":"15","author":"Langsjoen","year":"1994","journal-title":"Mol Aspects Med"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2009.07.003_bib47","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/S0098-2997(97)00006-X","article-title":"Treatment of hypertrophic cardiomyopathy with coenzyme Q10","volume":"18","author":"Langsjoen","year":"1997","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12033-007-0052-y","article-title":"Bioenergetic and antioxidant properties of coenzyme q10: recent developments","volume":"37","author":"Littarru","year":"2007","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib49","first-page":"291","article-title":"Deficiency of coenzyme Q10 in human heart disease. Part I","volume":"42","author":"Littarru","year":"1972","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib50","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1152\/ajplegacy.1965.208.6.1275","article-title":"Effects of ubiquinone and related substances on secretion of aldosterone and cortisol","volume":"208","author":"Louis","year":"1965","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.07.003_bib88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0008-6363(00)00241-8","article-title":"Mitochondrial pathology in cardiac failure","volume":"49","author":"Marin-Garcia","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/1071-9164(95)90003-9","article-title":"Impaired mitochondrial function in idiopathic dilated cardiomyopathy: biochemical and molecular analysis","volume":"1","author":"Marin-Garcia","year":"1995","journal-title":"J Card Fail"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.07.003_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1254\/jphs.FP0072365","article-title":"Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome","volume":"107","author":"Masaru","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF02531617","article-title":"Quinone and quinols as inhibitors of lipid peroxidation","volume":"1","author":"Mellors","year":"1966","journal-title":"Lipids"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib54","first-page":"71","article-title":"Coenzyme Q10: is there a clinical role and a case for measurement?","volume":"29","author":"Molyneux","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib55","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jacc.2008.07.044","article-title":"Coenzyme Q10: an independent predictor of mortality in chronic heart failure","volume":"52","author":"Molyneux","year":"2008","journal-title":"Am Coll Cardiol"},{"issue":"Supplement 8","key":"10.1016\/j.pharmthera.2009.07.003_bib56","first-page":"S134","article-title":"Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study","volume":"71","author":"Morisco","year":"1993","journal-title":"J Mol Med Issue"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/biof.5520180210","article-title":"Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of \u201cQ-symbio\u201d\u2014a multinational trial","volume":"18","author":"Mortensen","year":"2003","journal-title":"Biofactors"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.07.003_bib59","first-page":"497","article-title":"Deficiency of coenzyme Q10 in myocardial failure","volume":"10","author":"Mortensen","year":"1984","journal-title":"Drugs Exp Clin Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.07.003_bib60","first-page":"581","article-title":"Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure","volume":"11","author":"Mortensen","year":"1985","journal-title":"Drugs Exp Clin Res"},{"issue":"2\u20134","key":"10.1016\/j.pharmthera.2009.07.003_bib62","first-page":"285","article-title":"Coenzyme Q10 treatment in serious heart failure","volume":"9","author":"Munkholm","year":"2008","journal-title":"BioFactors"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib63","unstructured":"Nakamura, T., Sanma, H., Himeno, M., and Kato, K. (1980).Transfer of exogenous coenzyme Q10 to the inner membrane of heart mitochondria in rats. K. Folkers, Y. Yamamura (Eds.) Biomedical and clinical aspects of coenzyme Q. Elsevier\/North-Holland Press, 2:3\u201314."},{"issue":"1","key":"10.1016\/j.pharmthera.2009.07.003_bib64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0003-2697(68)90018-3","article-title":"Determination and levels of coenzyme Q10 in human blood","volume":"23","author":"Redalieu","year":"1968","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jtcvs.2004.03.034","article-title":"Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue","volume":"129","author":"Rosenfeldt","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.jhh.1002138","article-title":"Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials","volume":"21","author":"Rosenfeldt","year":"2007","journal-title":"J Human Hypertens"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0022-3476(94)70308-6","article-title":"Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies","volume":"124","author":"Rustin","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib68","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2006.03.007","article-title":"The impact of coenzyme Q10 on systolic function in patients with chronic heart failure","volume":"12","author":"Sander","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib69","series-title":"Effect of coenzyme Q10 on ischemia-induced ST-segment depression: a double-blind, placebo-controlled crossover study","first-page":"358","volume":"Vol. 5","author":"Schardt","year":"1986"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.07.003_bib70","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0008-6363(02)00826-X","article-title":"Relevance of Na+\u2013Ca2+ exchange in heart failure","volume":"57","author":"Schillingera","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"1\u20134","key":"10.1016\/j.pharmthera.2009.07.003_bib71","first-page":"125","article-title":"Statin cardiomyopathy: a potential role for coenzyme Q10 therapy for statin induced changes in diastolic LV performance: description of a clinical protocol","volume":"18","author":"Silver","year":"2003","journal-title":"Bio factors"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1007764616025","article-title":"Randomized, double-blind placebo controlled trial of coenzyme Q10 in patients with acute myocardial infarction","volume":"12","author":"Singh","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.jhh.1000778","article-title":"Effect of hydrosoluble coenzyme Q10 on blood pressure and insulin resistance in hypertensive patients with coronary artery disease","volume":"13","author":"Singh","year":"1999","journal-title":"J Hum Hypertens"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.07.003_bib74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1023408031111","article-title":"Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction","volume":"246","author":"Singh","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0098-2997(97)00042-3","article-title":"Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials","volume":"18","author":"Soja","year":"1997","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib76","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1073\/pnas.88.5.1646","article-title":"Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does a-tocopherol","volume":"88","author":"Stoker","year":"1991","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.07.003_bib77","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0003-4975(95)01120-X","article-title":"Effects of short-term supplementation with coenzyme Q10 on myocardial protection during cardiac operations","volume":"61","author":"Taggart","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"18","key":"10.1016\/j.pharmthera.2009.07.003_bib78","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/eurheartj\/ehm267","article-title":"Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study","volume":"28","author":"Tiano","year":"2007","journal-title":"Eur Heart J"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.07.003_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.03.006","article-title":"Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells","volume":"566","author":"Tsuneki","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.07.003_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s003950050055","article-title":"Heart failure: is there an energy deficit contributing to contractile dysfunction?","volume":"93","author":"Vogt","year":"1998","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib81","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0735-1097(99)00064-9","article-title":"Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure","volume":"33","author":"Watson","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib82","first-page":"339","article-title":"Coenzyme Q10 therapy and exercise duration in stable angina","volume":"Vol. 6","author":"Wilson","year":"1991"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib83","first-page":"404","article-title":"Deficiency of activity of succinate dehydrogenase-coenzyme Q10 reductase in leukocytes from patients with essential hypertension","volume":"44","author":"Yamagami","year":"1974","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib84","series-title":"Effect of coenzyme Q10 on essential hypertension: a double-blind controlled study","first-page":"337","volume":"Vol. 5","author":"Yamagami","year":"1986"},{"key":"10.1016\/j.pharmthera.2009.07.003_bib85","first-page":"168","article-title":"Clinical use of coenzyme-Q for treatment of cardiovascular disease","volume":"31","author":"Yamamura","year":"1967","journal-title":"Jpn Circ J"},{"issue":"12","key":"10.1016\/j.pharmthera.2009.07.003_bib86","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jnutbio.2004.06.008","article-title":"Ginkgo biloba extract (EGb 761) inhibits beta-amyloid production by lowering free cholesterol levels","volume":"15","author":"Yao","year":"2004","journal-title":"Nutr Biochem"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.07.003_bib87","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0039-6060(96)80287-X","article-title":"Coenzyme Q10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect","volume":"120","author":"Yokoyama","year":"1996","journal-title":"Surgery"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725809001429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725809001429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T14:01:07Z","timestamp":1558447267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725809001429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0163725809001429"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2009.07.003","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}